Immunosuppressive regimen
Showing 1 - 25 of >10,000
Renal Failure, Renal Insufficiency, Renal Disease Trial in Dresden (Advagraf)
Active, not recruiting
- Renal Failure
- +3 more
-
Dresden, GermanyUniversitätsklinikum Carl Gustav Carus
Aug 2, 2022
Renal Allograft Recipients Trial in Worldwide (Belatacept, Tacrolimus, Cyclosporine A)
Recruiting
- Renal Allograft Recipients
- Belatacept
- +5 more
-
Birmingham, Alabama
- +14 more
Oct 24, 2022
Kidney Transplant Recipients Trial in Xi'an (Mycophenolate Mofetil Capsules)
Recruiting
- Kidney Transplant Recipients
- Mycophenolate Mofetil Capsules
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital Xi'an Jiaotong University
May 25, 2022
Renal Transplant Rejection, Induction Therapy Trial (Rabbit Anti thymocyte globulin (rATG), Basiliximab)
Not yet recruiting
- Renal Transplant Rejection
- Induction Therapy
- Rabbit Anti thymocyte globulin (rATG)
- Basiliximab
- (no location specified)
Sep 22, 2022
Renal Insufficiency, Kidney Transplantation Trial in Amsterdam, Groningen, Leiden (tacrolimus OD, mycophenolic acid,
Completed
- Renal Insufficiency
- Kidney Transplantation
- tacrolimus OD, mycophenolic acid, prednisolone
-
Amsterdam, Netherlands
- +2 more
Dec 20, 2021
Multiple Sclerosis Trial in Saint Petersburg (Fludarabine Phosphate for Injection)
Recruiting
- Multiple Sclerosis
- Fludarabine Phosphate for Injection
-
Saint Petersburg, Russian FederationFirst Pavlov State Medical University of St. Petersburg
Apr 14, 2023
Anti-Mullerian Hormone Deficiency, Immunosuppression, Ovarian Reserve Trial in Wroclaw (AMH level measurement)
Completed
- Anti-Mullerian Hormone Deficiency
- +3 more
- AMH level measurement
-
Wrocław, PolandNephrology and Transplantation Clinic University Hospital in Wro
Feb 18, 2021
Type 1 Diabetes Trial in Duarte (Allogenic Human Islet Cells, Immunosuppressive Agents, Gastrin 17)
Recruiting
- Type 1 Diabetes Mellitus
- Allogenic Human Islet Cells
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 17, 2022
Severe Aplastic Anemia Trial run by the NHLBI (ATG+Rapamune+cyclosporine, ATG+cyclosporine)
Completed
- Severe Aplastic Anemia
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 29, 2021
Primary Renal Allograft Candidate, Kidney Transplantation Trial in Birmingham, San Francisco, Atlanta (Anti-thymocyte Globulin
Terminated
- Primary Renal Allograft Candidate
- Kidney Transplantation
- Anti-thymocyte Globulin (Rabbit)
- +5 more
-
Birmingham, Alabama
- +2 more
Nov 24, 2020
Renal Function and Transplant Rejection Rate in Lung Transplant
Completed
- Lung Transplant; Complications
- Chronic Kidney Diseases
-
Giessen, Hessen, GermanyUniversity Hospital Giessen and Marburg
Sep 25, 2019
CNS Leukemia, Allogeneic Hematopoietic Stem Cell Transplantation Trial in Xi'an (TBF regimen, modified BuCY2 regimen)
Not yet recruiting
- Central Nervous System Leukemia
- Allogeneic Hematopoietic Stem Cell Transplantation
- TBF regimen
- modified BuCY2 regimen
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xi'an Jiaotong University
Dec 26, 2022
Kidney Transplantation, Kidney Transplant Rejection Trial in Los Angeles (Twice-daily Tacrolimus, Once-daily envarsus XR,
Recruiting
- Kidney Transplantation
- Kidney Transplant Rejection
- Twice-daily Tacrolimus
- +5 more
-
Los Angeles, CaliforniaUniversity of Southern California
Jun 6, 2022
Sickle Cell Disease Trial in Duarte (Hematopoietic stem cell transplantation)
Recruiting
- Sickle Cell Disease
- Hematopoietic stem cell transplantation
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 14, 2022
Kidney Transplant Rejection Trial (Enteric-Coated Mycophenolate Sodium (EC-MPS))
Not yet recruiting
- Kidney Transplant Rejection
- Enteric-Coated Mycophenolate Sodium (EC-MPS)
- (no location specified)
May 23, 2023
Lung Transplantation Trial in Germany (standard therapy, Everolimus)
Secondary Malignant Tumor of Retroperitoneum, Secondary Malignant Tumor of Peritoneum, Pseudomyxoma Peritonei Trial in Cleveland
Not yet recruiting
- Secondary Malignant Neoplasm of Retroperitoneum
- +2 more
- Intestinal, Multivisceral or Modified Multivisceral Transplantation
- +3 more
-
Cleveland, OhioCleveland Clinic Digestive Disease & Surgery Institute (DDSI), C
Oct 10, 2023
BIOtechnology Applied to Renal TRansplantation With
Recruiting
- Kidney Transplant Failure and Rejection
- Immunobiogram
-
Brasil, Brazil
- +14 more
Apr 14, 2023
End Stage Kidney Disease, Immunological Tolerance, Kidney Transplant Failure and Rejection Trial in Los Angeles (Donor CD34+,
Not yet recruiting
- End Stage Kidney Disease
- +3 more
- Donor CD34+, CD3+. and belumosudil
-
Los Angeles, CaliforniaUniversity of California, Los Angeles
Apr 6, 2023
End Stage Renal Disease, Rejection of Renal Transplant Trial in Chicago (Tacrolimus, Tacrolimus Extended Release Oral Tablet
Completed
- End Stage Renal Disease
- Rejection of Renal Transplant
- Tacrolimus
- Tacrolimus Extended Release Oral Tablet [Envarsus]
-
Chicago, IllinoisNorthwestern University
Jan 12, 2023
Carcinoma, Hepatocellular Trial in United States (Everolimus, Tacrolimus, Myfortic)
Active, not recruiting
- Carcinoma, Hepatocellular
- Everolimus
- +4 more
-
San Francisco, California
- +8 more
Jul 19, 2022
IBD Trial (standard hepatitis B vaccine, accelerated HBV Vaccine)
Not yet recruiting
- Inflammatory Bowel Diseases
- standard hepatitis B vaccine
- accelerated HBV Vaccine
- (no location specified)
Jul 27, 2023
Thymoglobulin Dose Trial in Fortaleza (Thymoglobulin)
Unknown status
- Thymoglobulin Dose
-
Fortaleza, Ceará, BrazilTransplant ward of the Hospital do Fortaleza
Feb 20, 2019